Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-15-004878)

Filing Details

Accession Number:: 0001104659-15-004878
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-01-28 06:51:07
Reporting Period:: 2015-01-22

Filing Date:: 2015-01-28
Accepted Time:: 2015-01-28 06:51:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178670	Alnylam Pharmaceuticals Inc.	ALNY	Pharmaceutical Preparations (2834)	770602661

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1121404	Sanofi	54 Rue La Boetie Paris I0 75008		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-01-22	196,251	$9,317.00	9,307,037	No	4	P	Indirect	Via wholly-owned subsidiary, Genzyme Corp.
Common Stock	Acquisiton	2015-01-26	647,448	$95.00	9,954,485	No	4	P	Indirect	Via wholly-owned subsidiary, Genzyme Corp.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Via wholly-owned subsidiary, Genzyme Corp.
No	4	P	Indirect	Via wholly-owned subsidiary, Genzyme Corp.

Footnotes

Genzyme Corporation entered into a 60-day lock-up agreement (which may be extended under certain circumstances) which covers the 843,699 newly acquired shares.